LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 310

Search options

  1. Article ; Online: Synthesis and Characterization of Cobalt-Doped Ferrites for Biomedical Applications.

    Kiani, Muhammad Naeem / Butt, Muhammad Shoaib / Gul, Iftikhar Hussain / Saleem, Mohsin / Irfan, Muhammad / Baluch, Abrar H / Akram, Muhammad Aftab / Raza, Mohsin Ali

    ACS omega

    2023  Volume 8, Issue 4, Page(s) 3755–3761

    Abstract: Novel materials for biomedical applications are in critical need of time. In the present work, the antibacterial properties of ... ...

    Abstract Novel materials for biomedical applications are in critical need of time. In the present work, the antibacterial properties of Co
    Language English
    Publishing date 2023-01-18
    Publishing country United States
    Document type Journal Article
    ISSN 2470-1343
    ISSN (online) 2470-1343
    DOI 10.1021/acsomega.2c05226
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: An Enhanced Agile V-Model: Conformance to regulatory bodies and experiences from model's adoption to medical device development.

    Khan, Aliya A / Akram, Muhammad U / Butt, Wasi H / Sirshar, Mehreen

    Heliyon

    2024  Volume 10, Issue 6, Page(s) e26928

    Abstract: Context: Medical devices fall under the broad topic encompass everything from basic hardware to integrated software systems. The integration of software into hardware devices is not simple due to requirements of regional regulatory bodies. Therefore, ... ...

    Abstract Context: Medical devices fall under the broad topic encompass everything from basic hardware to integrated software systems. The integration of software into hardware devices is not simple due to requirements of regional regulatory bodies. Therefore, medical businesses need to oversee not only the creation of devices but also the observance of guidelines and standards established by regulatory bodies. While plan-driven methodologies prevented software from evolving or changing, agile methodologies have inherent characteristics of insufficient planning and documentation.
    Objectives: The objective of our research is to propose a suitable process model for medical device development, keeping in mind the regulatory requirements.
    Methods: First, based on the detailed analysis of literature and McHughs proposed model, we suggested the Enhanced Agile V-Model (EAV), which combines plan-driven and agile approaches. Second, we mapped the proposed model to the MDEVSPICE framework to confirm that it adhered to the rules outlined in the standard IEC62304. Finally, the proposed model is evaluated through implication to case study of wave therapeutic medical device.
    Results: The support of both agile and waterfall approach in EAV model helps in accommodating new requirements in the medical devices and the proposed systems engineering approach helps in hardware and software integration. The mapping of the EAV model to the MDEVSPICE shows complete compliance. Moreover, the implication of the proposed model has been clearly shown statistically and successfully implemented in our case study. Further, device usability and efficiency metrics showed confidence of P < 0.05 and for device safety and efficiency, we conducted an experiment which shows significant improvement in selected parameters.
    Conclusion: The proposed model shows conformance to regulatory standards, and successfully implemented in development of wave therapeutic device. However, its applicability to more compact and straightforward medical products is unknown and can be determined by using this model to analyze the performance of other medical products.
    Language English
    Publishing date 2024-02-28
    Publishing country England
    Document type Journal Article
    ZDB-ID 2835763-2
    ISSN 2405-8440
    ISSN 2405-8440
    DOI 10.1016/j.heliyon.2024.e26928
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article: A Case of Disseminated Herpes Zoster With Polyneuropathy Following the Third Dose of the Pfizer-BioNTech Vaccine.

    Riazuddin, Muhammad / Jefri, Mona H / Butt, Muhammad I / Alsalamah, Hathami I / Ali Sheikh, Aamir Nadeem M

    Cureus

    2023  Volume 15, Issue 1, Page(s) e33962

    Abstract: SARS-CoV-2 pandemic resulted in the fast development of new vaccines, which helped contain the pandemic, but some adverse events started to rise. Recently, post-administration of mRNA-based vaccines, varicella-zoster virus (VZV) reactivation was reported. ...

    Abstract SARS-CoV-2 pandemic resulted in the fast development of new vaccines, which helped contain the pandemic, but some adverse events started to rise. Recently, post-administration of mRNA-based vaccines, varicella-zoster virus (VZV) reactivation was reported. We report a case of disseminated herpes zoster with polyneuropathy and cerebrospinal fluid (CSF) findings following the Pfizer-BioNTechvaccine. Our observation aims to increase clinicians' awareness of a possible relationship between herpes zoster reactivation and SARS-CoV-2 vaccines.
    Language English
    Publishing date 2023-01-19
    Publishing country United States
    Document type Case Reports
    ZDB-ID 2747273-5
    ISSN 2168-8184
    ISSN 2168-8184
    DOI 10.7759/cureus.33962
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Outbreak of acute hepatitis of unknown etiology in children: The critical role of healthcare professionals in neutralizing misleading narratives during the COVID-19 pandemic.

    Khan, Yusra H / Mallhi, Tauqeer H / Alanazi, Abdullah S / Butt, Muhammad H / Khan, Amjad / Salman, Muhammad

    Journal of medical virology

    2022  Volume 94, Issue 9, Page(s) 4063–4064

    MeSH term(s) COVID-19/epidemiology ; Child ; Delivery of Health Care ; Disease Outbreaks ; Health Personnel ; Hepatitis ; Humans ; Pandemics
    Language English
    Publishing date 2022-05-12
    Publishing country United States
    Document type Letter
    ZDB-ID 752392-0
    ISSN 1096-9071 ; 0146-6615
    ISSN (online) 1096-9071
    ISSN 0146-6615
    DOI 10.1002/jmv.27819
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: A systematic metadata harvesting workflow for analysing scientific networks.

    Butt, Bilal H / Rafi, Muhammad / Sabih, Muhammad

    PeerJ. Computer science

    2021  Volume 7, Page(s) e421

    Abstract: One of the disciplines behind the science of science is the study of scientific networks. This work focuses on scientific networks as a social network having different nodes and connections. Nodes can be represented by authors, articles or journals while ...

    Abstract One of the disciplines behind the science of science is the study of scientific networks. This work focuses on scientific networks as a social network having different nodes and connections. Nodes can be represented by authors, articles or journals while connections by citation, co-citation or co-authorship. One of the challenges in creating scientific networks is the lack of publicly available comprehensive data set. It limits the variety of analyses on the same set of nodes of different scientific networks. To supplement such analyses we have worked on publicly available citation metadata from Crossref and OpenCitatons. Using this data a workflow is developed to create scientific networks. Analysis of these networks gives insights into academic research and scholarship. Different techniques of social network analysis have been applied in the literature to study these networks. It includes centrality analysis, community detection, and clustering coefficient. We have used metadata of Scientometrics journal, as a case study, to present our workflow. We did a sample run of the proposed workflow to identify prominent authors using centrality analysis. This work is not a bibliometric study of any field rather it presents replicable Python scripts to perform network analysis. With an increase in the popularity of open access and open metadata, we hypothesise that this workflow shall provide an avenue for understanding scientific scholarship in multiple dimensions.
    Language English
    Publishing date 2021-03-10
    Publishing country United States
    Document type Journal Article
    ISSN 2376-5992
    ISSN (online) 2376-5992
    DOI 10.7717/peerj-cs.421
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Convergent synthesis, kinetics insight and allosteric computational ascriptions of thiazole-(5-aryl)oxadiazole hybrids embraced with propanamides as alkaline phosphatase inhibitors.

    Butt, Abdul Rehman Sadiq / Abbasi, Muhammad Athar / Aziz-Ur-Rehman / Siddiqui, Sabahat Zahra / Muhammad, Shabbir / Raza, Hussain / Shah, Syed Adnan Ali / Shahid, Muhammad / Alsehemi, Abdullah G / Kim, Song Ja

    RSC advances

    2023  Volume 13, Issue 20, Page(s) 13798–13808

    Abstract: ... a unique series of bi-heterocyclic hybrids, 8a-h, was synthesized in a convergent manner. The structures ...

    Abstract Considering the varied pharmacological prominence of thiazole and oxadiazole heterocyclic moieties, a unique series of bi-heterocyclic hybrids, 8a-h, was synthesized in a convergent manner. The structures of newly synthesized compounds were characterized by
    Language English
    Publishing date 2023-05-15
    Publishing country England
    Document type Journal Article
    ISSN 2046-2069
    ISSN (online) 2046-2069
    DOI 10.1039/d3ra01348k
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: A systematic metadata harvesting workflow for analysing scientific networks

    Bilal H. Butt / Muhammad Rafi / Muhammad Sabih

    PeerJ Computer Science, Vol 7, p e

    2021  Volume 421

    Abstract: One of the disciplines behind the science of science is the study of scientific networks. This work focuses on scientific networks as a social network having different nodes and connections. Nodes can be represented by authors, articles or journals while ...

    Abstract One of the disciplines behind the science of science is the study of scientific networks. This work focuses on scientific networks as a social network having different nodes and connections. Nodes can be represented by authors, articles or journals while connections by citation, co-citation or co-authorship. One of the challenges in creating scientific networks is the lack of publicly available comprehensive data set. It limits the variety of analyses on the same set of nodes of different scientific networks. To supplement such analyses we have worked on publicly available citation metadata from Crossref and OpenCitatons. Using this data a workflow is developed to create scientific networks. Analysis of these networks gives insights into academic research and scholarship. Different techniques of social network analysis have been applied in the literature to study these networks. It includes centrality analysis, community detection, and clustering coefficient. We have used metadata of Scientometrics journal, as a case study, to present our workflow. We did a sample run of the proposed workflow to identify prominent authors using centrality analysis. This work is not a bibliometric study of any field rather it presents replicable Python scripts to perform network analysis. With an increase in the popularity of open access and open metadata, we hypothesise that this workflow shall provide an avenue for understanding scientific scholarship in multiple dimensions.
    Keywords Digital libraries ; Network analysis ; Centrality measures ; Citation network ; Collaboration network ; Python ; Electronic computers. Computer science ; QA75.5-76.95
    Subject code 001
    Language English
    Publishing date 2021-03-01T00:00:00Z
    Publisher PeerJ Inc.
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  8. Article: Adipose Tissue and Umbilical Cord Tissue: Potential Sources of Mesenchymal Stem Cells for Liver Fibrosis Treatment.

    Ghufran, Hafiz / Azam, Maryam / Mehmood, Azra / Umair, Muhammad / Baig, Maria T / Tasneem, Saba / Butt, Hira / Riazuddin, Sheikh

    Journal of clinical and experimental hepatology

    2024  Volume 14, Issue 4, Page(s) 101364

    Abstract: ... differentiation potential. However, AT-MSCs demonstrated a shorter doubling time (58.2 ± 7.3 vs. 82.3 ± 4.3 h ...

    Abstract Background/aims: Mesenchymal stem cells (MSCs) are potential alternatives for liver fibrosis treatment; however, their optimal sources remain uncertain. This study compares the ex-vivo expansion characteristics of MSCs obtained from adipose tissue (AT) and umbilical cord (UC) and assesses their therapeutic potential for liver fibrosis treatment.
    Methods: Since MSCs from early to mid-passage numbers (P2-P6) are preferable for cellular therapy, we investigated the growth kinetics of AT-MSCs and UC-MSCs up to P6 and evaluated their therapeutic effects in a rat model of liver fibrosis induced by diethylnitrosamine.
    Results: Results from the expansion studies demonstrated that both cell types exhibited bona fide characteristics of MSCs, including surface antigens, pluripotent gene expression, and differentiation potential. However, AT-MSCs demonstrated a shorter doubling time (58.2 ± 7.3 vs. 82.3 ± 4.3 h;
    Conclusion: AT-MSCs and UC-MSCs effectively reduce liver fibrosis. However, adipose cultures display an advantage by yielding a higher number of MSCs in a shorter duration, rendering them a viable choice for scenarios requiring immediate single-dose administration, often encountered in clinical settings.
    Language English
    Publishing date 2024-02-12
    Publishing country India
    Document type Journal Article
    ISSN 0973-6883
    ISSN 0973-6883
    DOI 10.1016/j.jceh.2024.101364
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Comparative molecular docking analysis for analyzing the inhibitory effect of Anakinra and Ustekinumab against IL17F.

    Nisar, Haseeb / Attique, Syed Awais / Javaid, Anum / Ain, Qurat Ul / Butt, Fatima / Zaid, Muhammad / Shahid, Samiah / Hassan Nasir, Muhammad / Sadaf, Saima

    Journal of biomolecular structure & dynamics

    2023  Volume 41, Issue 22, Page(s) 13302–13313

    Abstract: ... Communicated by Ramaswamy H. Sarma. ...

    Abstract Interleukin 17 F is a member of IL-17 cytokine family with a 50% structural homology to IL-17A and plays a significant role either alone or in combination with IL-17A towards inflammation in Rheumatoid arthritis (RA). A growing number of drugs targeting IL-17 pathway are being tested against population specific disease markers. The major objective of this research was to investigate the anti-inflammatory effect of Anakinra (an IL-1 R1 inhibitor) and Ustekinumab (an IL-12 and IL-23 inhibitor) by targeting IL17F. The three dimensional structures of IL17F was taken from PDB while structures of drugs were taken from PubChem database. Docking was performed using MOE and Schrodinger ligand docking software and binding energies, including s-score using London-dG fitness function and glide score using glide internal energy function, between drug and targets were compared. Furthermore, Protein-Drug complex were subjected to 150 ns Molecular Dynamics (MD) Simulations using Schrodinger's Desmond Module. Docking and MD simulation results suggest anakinra as a more potent IL17F inhibitor and forming a more structurally stable complex.Communicated by Ramaswamy H. Sarma.
    MeSH term(s) Interleukin-17 ; Ustekinumab/pharmacology ; Molecular Docking Simulation ; Interleukin 1 Receptor Antagonist Protein/pharmacology ; Molecular Dynamics Simulation
    Chemical Substances Interleukin-17 ; Ustekinumab (FU77B4U5Z0) ; Interleukin 1 Receptor Antagonist Protein
    Language English
    Publishing date 2023-01-30
    Publishing country England
    Document type Journal Article
    ZDB-ID 49157-3
    ISSN 1538-0254 ; 0739-1102
    ISSN (online) 1538-0254
    ISSN 0739-1102
    DOI 10.1080/07391102.2023.2173299
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Use of Endpoints in Phase III Randomized Controlled Trials for Hematopoietic Stem Cell Transplantation Over the Last 15 Years: A Systematic Review.

    Shahzad, Moazzam / Khalid, Muhammad Fareed / Amin, Muhammad Kashif / Ammad-Ud-Din, Mohammad / Ilyas, Usman / Mushtaq, Ali H / Butt, Atif / Anwar, Iqra / Chaudhary, Sibgha Gull / Ahmed, Nausheen / Shune, Leyla / Singh, Anurag K / Abhyankar, Sunil H / McGuirk, Joseph P / Mushtaq, Muhammad Umair

    Hematology/oncology and stem cell therapy

    2024  Volume 17, Issue 2, Page(s) 88–94

    Abstract: This systematic review aimed to evaluate the proportion of primary and secondary endpoints in hematopoietic stem cell transplant (HSCT) phase III randomized clinical trials (RCTs) and analyze their trends in time and study sponsorship status. The Chi- ... ...

    Abstract This systematic review aimed to evaluate the proportion of primary and secondary endpoints in hematopoietic stem cell transplant (HSCT) phase III randomized clinical trials (RCTs) and analyze their trends in time and study sponsorship status. The Chi-square test and logistic regression analyses were performed using SPSS version 28. A total of 147 HSCT phase III RCTs from 2006 to 2021 reported 197 primary and 600 secondary endpoints. Overall survival (OS, 17 %), progression-free survival (PFS, 15 %), graft versus host disease (GVHD, 8 %), event-free survival (EFS, 8 %), and organ function (8 %) were the most common primary endpoints. GVHD (12.3 %, n = 74), safety/toxicity/adverse events (11.8 %, n = 71), OS (11.5 %, n = 69), PFS (9.3 %, n = 56), and relapse rate (RR; 7.5 %, n = 45) were the most common secondary endpoints during 2006-2021. After 2013, an increase was noted in the use of PFS as a primary endpoint (12 %-18 %, p = 0.196), while the use of OS as a primary endpoint declined (20 %-13 %, p = 0.170). An increase was observed in using the secondary endpoints RR (5 %-10 %, p = 0.047) and NRM (3 %-6 %, p = 0.047). EFS was used more (14 % vs. 4 %, p = 0.012) than ORR (11 % vs. 2 %, p = 0.003) as a primary endpoint in pharmaceutical-compared to non-pharmaceutical-sponsored studies. As secondary endpoints, the use of EFS (4 % vs. 1 %, p = 0.013) and ORR (4 % vs. 1 %, p = 0.028) was higher, whereas that of organ systems/functions (1.5 % vs. 5.5 %, p = 0.022) and GVHD (6.5 % vs. 15 %, p = 0.002) was lower in pharmaceutical-compared to non-pharmaceutical sponsored studies. GVHD-free relapse-free survival was reported as a primary endpoint in 2 % of studies, while only 5 % reported quality of life as a secondary endpoint. We described commonly used endpoints in HSCT phase III RCTs and patterns in their use over time by funding source and study intervention category.
    MeSH term(s) Humans ; Clinical Trials, Phase III as Topic ; Graft vs Host Disease/etiology ; Hematopoietic Stem Cell Transplantation/adverse effects ; Pharmaceutical Preparations ; Randomized Controlled Trials as Topic ; Transplantation, Homologous
    Chemical Substances Pharmaceutical Preparations
    Language English
    Publishing date 2024-03-30
    Publishing country Saudi Arabia
    Document type Journal Article ; Systematic Review
    ZDB-ID 2651893-4
    ISSN 2589-0646 ; 1658-3876
    ISSN (online) 2589-0646
    ISSN 1658-3876
    DOI 10.56875/2589-0646.1118
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top